DE2026740A1 - Arzneimittelzubereitung - Google Patents

Arzneimittelzubereitung

Info

Publication number
DE2026740A1
DE2026740A1 DE19702026740 DE2026740A DE2026740A1 DE 2026740 A1 DE2026740 A1 DE 2026740A1 DE 19702026740 DE19702026740 DE 19702026740 DE 2026740 A DE2026740 A DE 2026740A DE 2026740 A1 DE2026740 A1 DE 2026740A1
Authority
DE
Germany
Prior art keywords
calcium
cis
lecithin
suspension
phosphonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702026740
Other languages
German (de)
English (en)
Inventor
Donald Johnson Gsynedd; O'Neill Joseph Lawrence Lafayette Hill; Pa. Allen (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2026740A1 publication Critical patent/DE2026740A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE19702026740 1969-06-02 1970-06-01 Arzneimittelzubereitung Pending DE2026740A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82978569A 1969-06-02 1969-06-02

Publications (1)

Publication Number Publication Date
DE2026740A1 true DE2026740A1 (de) 1970-12-10

Family

ID=25255551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702026740 Pending DE2026740A1 (de) 1969-06-02 1970-06-01 Arzneimittelzubereitung

Country Status (13)

Country Link
US (1) US3678163A (enExample)
BE (1) BE750811A (enExample)
CA (1) CA931077A (enExample)
DE (1) DE2026740A1 (enExample)
DK (1) DK124989B (enExample)
FI (1) FI47961C (enExample)
FR (1) FR2051568B1 (enExample)
GB (1) GB1263654A (enExample)
IE (1) IE34331B1 (enExample)
IL (1) IL34552A (enExample)
NL (1) NL7006857A (enExample)
SE (1) SE370865B (enExample)
ZA (1) ZA703677B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2309211A1 (fr) * 1975-04-28 1976-11-26 Lilly Co Eli Suspension de cefazoline pour administration parenterale

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2522081A1 (de) * 1975-05-17 1976-11-25 Boehringer Mannheim Gmbh Antibiotisch wirksames praeparat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3351527A (en) * 1964-10-01 1967-11-07 American Home Prod Stabilized benzathine penicillin compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2309211A1 (fr) * 1975-04-28 1976-11-26 Lilly Co Eli Suspension de cefazoline pour administration parenterale

Also Published As

Publication number Publication date
FI47961B (enExample) 1974-01-31
DK124989B (da) 1972-12-18
CA931077A (en) 1973-07-31
US3678163A (en) 1972-07-18
IL34552A0 (en) 1970-07-19
ZA703677B (en) 1972-01-26
IE34331B1 (en) 1975-04-16
GB1263654A (en) 1972-02-16
FI47961C (fi) 1974-05-10
BE750811A (fr) 1970-11-23
IL34552A (en) 1973-02-28
FR2051568A1 (enExample) 1971-04-09
IE34331L (en) 1970-12-02
NL7006857A (enExample) 1970-12-04
FR2051568B1 (enExample) 1974-04-12
SE370865B (enExample) 1974-11-04

Similar Documents

Publication Publication Date Title
DE69128308T2 (de) Verfahren zur Herstellung von Hefe-Glucanen
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE2631947A1 (de) Konservierung von basischen arzneimittelzubereitungen
DE3205018A1 (de) Bifidobakterien vermehrendes mittel
DE69424156T2 (de) Arzneimittel zur prophylaxe und behandlung von katarakt
DE2746974A1 (de) Verwendung der pseudomonsaeure und ihrer salze und ester
DE69028877T2 (de) Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden
CH658787A5 (de) Pharmazeutische praeparate mit gleichbleibenden elutionseigenschaften.
DE2823346C2 (de) Verwendung von Glycinderivaten zur Herstellung von antiviriellen Mitteln
DE69229688T2 (de) Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten
DE2026740A1 (de) Arzneimittelzubereitung
DE69005978T2 (de) Verwendung von Actinonin zur Herstellung eines Medikamentes zur Inhibierung der Angiogenese.
DE2360118B2 (de) Impfstoff gegen Ferkel-Colibacillose
EP0263528B1 (de) Salmonella-Lebendimpfstoffe mit Wirtsspezies-angepassten Attenuierungshöhen und antiepidemischer Potenz
DE69626301T2 (de) Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
DE69227324T2 (de) Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält
DE2235294A1 (de) Pharmazeutische kombinationspraeparate
DE69528068T2 (de) Conagenine zur prävention und behandlung von diarrhöe
DE2312134C2 (de) Anthelmintikum
DE60108650T2 (de) 1-amino-alkylcyclohexanederivate als trypanocide mittel
DE2855306A1 (de) Mittel zur senkung der herzfrequenz
DE10129927B4 (de) Arzneimittel, enthaltend Derivate von Tetrahydrochinolin
DE69914937T2 (de) Betablocker und carbopol enthaltende ophtalmische zusammensetzung
EP0152860B1 (de) Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems
DE69828526T2 (de) Mittel gegen leishmaniasis, enthaltend glucopyrnosederivat als aktiven inhaltsstoff